Principal Investigator
Gilberto Lopes
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20250100
Clinical Trial Summary
A PHASE 1A/B, OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY, PHARMACOKINETICS, AND INITIAL EFFICACY OF 225AC-ABD147 IN PATIENTS WITH SMALL CELL LUNG CANCER AND LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG FOLLOWING PLATINUM-BASED CHEMOTHERAPY
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647